✦ LIBER ✦

Vemurafenib Response in 2 Patients With Posttransplant Refractory BRAF V600E–Mutated Multiple Myeloma

✍ Scribed by Sharman, J.P.; Chmielecki, J.; Morosini, D.; Palmer, G.A.; Ross, J.S.; Stephens, P.J.; Stafl, J.; Miller, V.A.; Ali, S.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vemurafenib in Patients With BRAF V600E

✍ Marcus C. Ravnan; Mazen S. Matalka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 600 KB

Clinical Responses to Vemurafenib in Pat

✍ Kim, Kevin B.; Cabanillas, Maria E.; Lazar, Alexander J.; Williams, Michelle D.; 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 744 KB

BRIM-1, -2 and -3 trials: improved survi

✍ Young, Kate; Minchom, Anna; Larkin, James 📂 Article 📅 2012 🏛 Future Medicine 🌐 English ⚖ 702 KB

Overwhelming response to Dabrafenib in a

✍ Giovanni Ponti, Aldo Tomasi, Giovanni Pellacani 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 196 KB

Phase 2 study of arsenic trioxide in pat

✍ Mohamad A. Hussein; Mansoor Saleh; Farhad Ravandi; James Mason; Robert M. Rifkin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

NQO1*2 polymorphism and response to trea

✍ Gabriele Buda; Valentina Maggini; Sara Galimberti; Roberto Barale; Anna Maria Ro 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 113 KB